BioSpace News Archive

SYNAPS Dx, a privately held company focused on the research, development and commercialization of diagnostics for neurodegenerative disorders and conditions, including Alzheimer’s Disease, announces the close of its Series A $10 million investment, including private equity, individual and family funds, and corporate investors.

AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological, COVID-19 and dry eye disease (DED) diagnostics, today announced the development of the second generation version of its Rapid Neutralizing Antibody Test for COVID-19.

Celsion Corporation, a clinical-stage development company focused on DNA mediated immunotherapy and next-generation nucleic vaccines, announces that Khursheed Anwer, Ph.D., executive vice president and chief science officer, will be presenting at the International Vaccines Congress being held virtually October 18-20, 2021.

SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an innovative global pharmaceutical company focused on developing treatments for central nervous system (CNS) disorders, announced that the results from two post-hoc analyses of the long-term, open-label, multicenter, Phase 3 safety study, C021, have been published online by the journal Epilepsia (here and here).

MilliporeSigma, the U.S. and Canadian Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the opening of its second Carlsbad, California-based facility, significantly expanding its CDMO footprint.

Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, has launched Tapestri Cell & Gene Therapy Solutions, enabling deep analytical characterization of genotype with phenotype simultaneously for quicker, more efficient workflows.

Veranex, the first concept-to-commercialization global service provider dedicated to the MedTech industry, today announced the acquisition of IMMR, a leading preclinical science organization that provides preclinical research, pathology evaluation and surgical training services to medical technology innovators.

Gregory Miller named CEO and joins the Board of Directors Tuomas Knowles, Scientific Co-Founder, assumes role of Chief Technology Officer Martin Kulander joins Company as Chief Operating Officer Joseph Grosso joins Company as Vice President of Oncology Translation Scientific Co-Founder, Dr. Sarah Teichmann, joins the Board of Directors

Mayo Clinic announced an agreement on Tuesday, Oct. 12 that will allow it to offer clinical-grade comprehensive cancer genomic sequencing to cancer patients who choose to participate.

Biotricity, Inc., a medical diagnostic and consumer healthcare technology company, announced that its Chief Executive Officer Waqaas Al Siddiq is scheduled to present in-person at the Virtual LD Micro Main Event XIV in-person on Wednesday, October 13, 2021 at 5:00 PM PT/ 8:00 PM ET.